Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.
Hassin O, Nataraj NB, Shreberk-Shaked M, Aylon Y, Yaeger R, Fontemaggi G, Mukherjee S, Maddalena M, Avioz A, Iancu O, Mallel G, Gershoni A, Grosheva I, Feldmesser E, Ben-Dor S, Golani O, Hendel A, Blandino G, Kelsen D, Yarden Y, Oren M. Hassin O, et al. Among authors: yarden y. Nat Commun. 2022 May 19;13(1):2800. doi: 10.1038/s41467-022-30481-7. Nat Commun. 2022. PMID: 35589715 Free PMC article.
EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.
Avraham R, Sas-Chen A, Manor O, Steinfeld I, Shalgi R, Tarcic G, Bossel N, Zeisel A, Amit I, Zwang Y, Enerly E, Russnes HG, Biagioni F, Mottolese M, Strano S, Blandino G, Børresen-Dale AL, Pilpel Y, Yakhini Z, Segal E, Yarden Y. Avraham R, et al. Among authors: yarden y. Sci Signal. 2010 Jun 1;3(124):ra43. doi: 10.1126/scisignal.2000876. Sci Signal. 2010. PMID: 20516477
Consistency test of the cell cycle: roles for p53 and EGR1.
Zwang Y, Oren M, Yarden Y. Zwang Y, et al. Among authors: yarden y. Cancer Res. 2012 Mar 1;72(5):1051-4. doi: 10.1158/0008-5472.CAN-11-3382. Epub 2012 Feb 7. Cancer Res. 2012. PMID: 22315347 Free PMC article. Review.
miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.
Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, Canu V, Mori F, Antoniani B, Di Benedetto A, Santoro R, Germoni S, De Angelis F, Cambria A, Avraham R, Grasso G, Strano S, Muti P, Mottolese M, Yarden Y, Domany E, Blandino G. Biagioni F, et al. Among authors: yarden y. EMBO Mol Med. 2012 Nov;4(11):1214-29. doi: 10.1002/emmm.201201483. EMBO Mol Med. 2012. PMID: 23125021 Free PMC article.
Tumor suppressor microRNAs: a novel non-coding alliance against cancer.
Blandino G, Fazi F, Donzelli S, Kedmi M, Sas-Chen A, Muti P, Strano S, Yarden Y. Blandino G, et al. Among authors: yarden y. FEBS Lett. 2014 Aug 19;588(16):2639-52. doi: 10.1016/j.febslet.2014.03.033. Epub 2014 Mar 26. FEBS Lett. 2014. PMID: 24681102 Free article. Review.
Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective study.
Muti P, Sacconi A, Hossain A, Donzelli S, Ben Moshe NB, Ganci F, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G. Muti P, et al. Among authors: yarden y. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2471-81. doi: 10.1158/1055-9965.EPI-14-0398. Epub 2014 Jul 29. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25073626 Free article.
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.
Cohen-Dvashi H, Ben-Chetrit N, Russell R, Carvalho S, Lauriola M, Nisani S, Mancini M, Nataraj N, Kedmi M, Roth L, Köstler W, Zeisel A, Yitzhaky A, Zylberg J, Tarcic G, Eilam R, Wigelman Y, Will R, Lavi S, Porat Z, Wiemann S, Ricardo S, Schmitt F, Caldas C, Yarden Y. Cohen-Dvashi H, et al. Among authors: yarden y. EMBO Mol Med. 2015 Mar;7(3):299-314. doi: 10.15252/emmm.201404134. EMBO Mol Med. 2015. PMID: 25678558 Free PMC article.
351 results